Michael K. May

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

Carolyn Discafani, Marion L. Carroll, M. Brawner Floyd et al. · Biochemical Pharmacology · 1999 · 111 citations

Life Sciences, Medicinal Chemistry, Pharmacology +11

Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria

Alexey Ruzin, Guy Singh, Anatoly Severin et al. · Antimicrobial Agents and Chemotherapy · 2004 · 93 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.

Frank Loganzo, Malathi Hari, Tami Annable et al. · PubMed · 2004 · 39 citations

Medicine, Oncology, Pharmacology +14

Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in α-tubulin

Frank Loganzo, Malathi Hari, Tami Annable et al. · Molecular Cancer Therapeutics · 2004 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16

Two Photoaffinity Analogues of the Tripeptide, Hemiasterlin, Exclusively Label α-Tubulin

Maria Nunes, Joshua A. Kaplan, Joseph L. Wooters et al. · Biochemistry · 2005 · 25 citations

Medicine, Oncology, Pharmacology +15